Latest Commercial Operations News

Cobalt Blue Holdings has secured a pivotal three-year contract with Glencore to supply up to 50% of feedstock for its upcoming Kwinana Cobalt Refinery, marking a major step in advancing Australia's critical minerals ambitions.

Infratil Limited reported a robust FY2025 with operational EBITDAF nearing NZ$1 billion, driven by strong performances across its core infrastructure sectors and a strategic capital raise to fuel CDC Data Centres’ expansion.

4DMedical has submitted its CT:VQ lung imaging technology for FDA clearance, aiming to disrupt the $1 billion US nuclear lung scan market with a non-nuclear, lower-cost alternative. Clinical studies show CT:VQ matches or exceeds existing nuclear imaging in accuracy and patient experience.

MTM Critical Metals has confirmed the scalability of its Flash Joule Heating reactor, paving the way for commercial operations at its Texas facility later this year. The modular design promises potential throughput beyond initial targets.

Minbos Resources advances its Cabinda Phosphate Project with strong sales interest and a $36 million financing package, positioning itself as a key player in Angola's agricultural transformation.

Genmin Limited secures a A$2 million unsecured loan from its non-executive Chair to support working capital as it advances the Baniaka iron ore project in Gabon.

Silex Systems reports steady progress on its TRL-6 uranium enrichment demonstration, targeting completion by end-2025, while securing initial US government funding to support commercialisation efforts.

Nanoveu Limited has successfully raised $2.3 million through a share placement to accelerate development and commercialization of its cutting-edge semiconductor, 3D visualization, and solar coating technologies.

ReNu Energy has completed the sale of its hydrogen division and is set to acquire Janus Electric, a pioneer in electric truck battery swapping, backed by a substantial capital raise to scale operations.

Renascor Resources reports significant engineering advances that increase high-value graphite production by 60%, reduce operating costs, and confirm a safer, eco-friendly purification process.

Mesoblast has commercially launched Ryoncil in the US for pediatric acute GVHD, backed by a strong cash position and advancing multiple cell therapy programs.

Austral Gold’s Q1 2025 report reveals a 15.4% drop in gold equivalent production at its Guanaco mine due to mine depletion and mill repairs, while refurbishment advances at Casposo aim to boost future output.